Quantitative analysis for Silence Therapeutics plc (SLN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Buy (92.0) (grade A). 30 signals analyzed (25 differentiated alt-data).
SLN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $7.70 | $6.89 | $7.11 |
| 2026-05-11 | $7.45 | $6.92 | $7.17 |
| 2026-05-21 | $6.58 | $6.11 | $6.49 |
| 2026-06-03 | $6.79 | $6.19 | $6.41 |
| 2026-06-15 | $7.05 | $6.70 | $7.00 |
| 2026-06-26 | $10.63 | $9.89 | $10.14 |
| 2026-07-09 | $10.42 | $9.73 | $9.86 |
| 2026-07-21 | $11.08 | $10.28 | $10.85 |
| 2026-07-31 | $11.69 | $10.47 | $10.49 |
| 2026-08-12 | $15.20 | $13.55 | $13.58 |
| 2026-08-24 | $13.59 | $13.10 | $13.29 |
| 2026-09-03 | $15.09 | $14.44 | $14.79 |
How Silence Therapeutics plc stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ACIU | AC Immune S.A. | $294M | — |
| STTK | Shattuck Labs, Inc. | $296M | — |
| STRO | Sutro Biopharma, Inc. | $301M | 74.0 |
| NAUT | Nautilus Biotechnology, Inc. | $302M | — |
View all Health Care stocks by valuation and signals →
Silence Therapeutics plc (SLN) scores Strong Buy (92.0), with no measured dimension below 51. Its highest are competitive moat at 92, valuation at 72, technicals at 67, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 92 |
| valuation | 72 |
| technicals | 67 |
| analyst consensus | 64 |
| earnings quality | 51 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Silence Therapeutics plc (SLN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/SLN"><img src="https://stoquant.com/badge/SLN.svg" alt="Silence Therapeutics plc (SLN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.